Related references
Note: Only part of the references are listed.Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis
Mohamed Abdel Aziz et al.
LANCET (2006)
Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence
CSM Currie et al.
BMC PUBLIC HEALTH (2005)
Achieving the millennium development goals for health - Cost effectiveness analysis of strategies for tuberculosis control in developing countries
R Baltussen et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis
M Viveiros et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Tuberculosis elimination in the Netherlands
MW Borgdorff et al.
EMERGING INFECTIOUS DISEASES (2005)
Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis
E Montoro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Treatment of multidrug-resistant tuberculosis in San Francisco: An outpatient-based approach
M Burgos et al.
CLINICAL INFECTIOUS DISEASES (2005)
Delay in the diagnosis of Turkish servicemen with pulmonary tuberculosis
O Okutan et al.
MILITARY MEDICINE (2005)
Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis
D Lemus et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis
P Jureen et al.
TUBERCULOSIS (2004)
Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis
ED Chan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Effect of drug resistance on the generation of secondary cases of tuberculosis
M Burgos et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Delay in the diagnosis of pulmonary tuberculosis, London, 1998-2000: analysis of surveillance data
A Rodger et al.
BRITISH MEDICAL JOURNAL (2003)
Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.
C Mitnick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Patient and health service delay in the diagnosis of pulmonary tuberculosis in Ethiopia
M Demissie et al.
BMC PUBLIC HEALTH (2002)
Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients:: a national cohort study in Peru
PG Suárez et al.
LANCET (2002)
Predictive model to identify positive tuberculosis skin test results during contact investigations
WC Bailey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997
M Narita et al.
CHEST (2001)
Medical progress: Management of tuberculosis in the United States
PM Small et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The treatment of multidrug-resistant tuberculosis in Turkey
K Tahaoglu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Global trends in resistance to antituberculosis drugs
MA Espinal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)